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Abstract: We report the results of seroepidemiological study of hepatitis E virus (HEV)
infection in 636 voluntary blood donors in four Provinces of Northern Thailand. The average
seroprevalence of anti-HEV was 8.7%, which is lower than previous reports from HEV en-
demic areas and even in the central Thailand. No significant differences of the prevalence
were found geographically and also by age and sex. Our findings suggest that Northern
Thailand belongs to an intermediate prevalence group of HEV infection between non-en-
demic and endemic regions and the improvement of socioeconomic and hygienic status
might control the spreading of HEV infection in this area.
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INTRODUCTION
Hepatitis E virus (HEV) is the main causative agent of acute non-A, non-B, non-C
hepatitis and transmitted via the fecal-oral route (Balayan et al, 1983; Reyes et al, 1990;
Bradley, 1990). The disease manifests usually a self-limited course, except in pregnant wo-
men,who suffer with a 15-25% fatally rate from fulminant hepatitis (Bradley, 1990; Tsega et
al., 1992). Outbreaks of hepaptitis E have been reported over a wide geographic area in many
developing countries, especially in tropical and subtropical areas (Myint et al., 1985; Uchida,
1992; Uchida et al., 1993; Mast and Krawczynski, 1996). Anti-HEV has been detected in
<5% of children under 10 years of age, increasing to 10 - 40% among adults >25 years of
age in HEV endemic countries (Tsega et al., 1992; Mast and Krawczynski, 1996). Several
sporadic cases of HEV infection have also been reported in industrialized countries, where
almost all are imported from endemic areas by immigrants, travelers or soldiers (DeCock et
al., 1987; Skidmore et al., 1991; Hino et al, 1991; Jardi et al., 1993; Bryan et al., 1994).
Received for publication, July 5, 2000
Contribution No. 4022 from the Institute of Tropical Medicine, Nagasaki University
136
Seroprevalence studies among blood donors in some non-endemic countries have found an
anti-HEV prevalence of 1 - 5% (Paul et al., 1994). The prevalence of anti-HEV in a previous
report were 15.7% in voluntary blood donors in Bangkok, 6.2% in children in Northeastern
Thailand and 2.3% in children in Southern Thailand, respectively (Poovorawan et al., 1996).
Northern Thailand is contiguous to Myanmar, where is one of the highly endemic areas of
HEV infection (Myint et al., 1985; Uchida et al., 1993). The aim of present study was to
determine the prevalence of HEV infection in voluntary blood donors in Northern Thailand.
MATERIALS AND METHODS
During the period of July 1998 and July 1999, 636 serum samples were collectted from
voluntary blood donors (446 males and 190 females, 17 to 60 years old) in Chiang Mai,
Chiang Rai, Lampang and Lamphun Provinces in Northern Thailand (Fig. 1) and tested for
the presence of anti-HEV using HEV antibody ELISA kit (ANOGEN; Yes Biotech Laborato-
ries Ltd., Ontario, Canda), which employed a qualitative sandwich immunoassay. The
microtiter plates provided in the kit has been pre-coated with a mixture of synthetic HEV
polypeptides that correspond to highly antigenic segment of essential amino acid sequences
derived from ORF-2 and ORF-3 of Chinese HEV strain. The procedures of the examination
were performed strictly with instruction manuals. The samples from positive result were
picked up for retest and only repeatedly reactive sera were considered positive. The


















Table 1 shows prevalence of anti-HEV in voluntary blood donors in Northern Thailand
by age and sex The average prevalence of anti-HEV in 636 voluntary blood donors in
Northern Thailand was 8.7%. The prevalence of anti-HEV in male (9.0%) was slightly higher
than in temale (7.9%). There were no significant differences of the prevalence by age and
sex.
Table 2 describes geographic prevalence of anti-HEV in Chiang Mai, Chiang Rai,
Lampang and Lamphun Provinces in Northern Thailand. No remarkable differences of the
prevalence of anti-HEV were found among these 4 Provinces.
Table 1. Seropprevalence of anti-HEV in voluntary blood donors in Northern Thailand by age (years) and sex
17-20 21-30 31-40 41-50 51-60 Total
Male 9/108 10/ 98 7/106 12/110 21 24 40/446
(8.4%) (10.2%) (6.6%) (10.9%) (8.4%) (9.0%)
Female II 38 51 60 6/ 56 3/ 32 O/ 4 15/190
(2.7%) (8.4%) (10.8%) (9.4%) (0.0%) (7.9%)
T otal 10/146 15/158 13/162 15/142 21 28 55/636
(6.9%) (9.5%) (8.1%) (10.6%) (7.2%) (8.7%)
Table 2. Seroprevalence of anti-HEV in 4 Provinces of Northtern Thailand
Chiang Mai Chiang Rai Lampang Lamphun Total
M ale H/148 13/135 5/ 67 III 96 40/446
(7.5%) (9.7%) (7.5%) (ll.5%) (9.0%)
F emale 71 62 3/ 38 21 47 3/ 43 15/190
(ll.3%) (7.9%) (4.3%) (7.0%) (7.9%)
Total 18/2 10 16/173 7/1 14 14/139 55/636
(8.6%) (9.3%) (6.1%) (10.1%) (8.7%)
DIS CUSSION
HEV infection is transmitted enterically and outbreaks are usually associated with fecal
contamination of the water supply (Balayan et al, 1983; Reyes et al., 1990; Bradley, 1990;
Uchida et al., 1992). HEV is prevalent in South and Southeast Asia, Africa, Middle East!
Central America and the former Soviet Union (Myint et al., 1985; Uchida, 1992; Arif et al.,
1994; Mast and Krawczynski, 1996). Although several sporadic cases have been reported
from industrialized countries, almost all are imported from endemic countries by travelers,
immigrants or soldiers (DeCock et al, 1987; Skidmore et al., 1991; Hino et al., 1991; Jardi et
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al., 1993). The prevalence of anti-HEV is <5% in children under 10 years of age and in-
creasing to 10 - 40% among adults >25 years of age in HEV endemic countries (Tsega et
al., 1992; Mast and Krawczynski, 1996). Northern Thailand is contiguous to Myanmar, where
is a highly endemic area of HEV infection with the historical experiences of several outbreaks
of the disease (Myint et al., 1985; Uchida, 1992; Uchida et al., 1993). In our study, average
seroprevalence of anti-HEV among 636 voluntary blood donors in Northern Thailand was
8.7% and there were no significant differences in each Provinces and also by age and sex. In
the recent study, seroprpevalence of anti-HEV in healthy blood donors was 15.7% in Bangkik
and increased by age, up to 25% in the age group over 50 (Poovorawan et al, 1996). Com-
paring with these reports, our findings indicate that prevalence of HEV infection in Northern
Thailand is lower than in the HEV endemic countries and even in the central Thailand, and
suggest that Northern Thailand has not experienced hepatitis E epidemics and belongs to an
intermediate prevalence region of HEV infection. Hepatitis A virus (HAV) is transmittted via
the fecal-oral route, similar manner to HEV and 90% of the general population developed the
anti-HAV by the age of 10 years in 1982 in Bangkok (Viranuvati et al., 1982). However,
epidemiological pattern of HAV infection in Chiang Mai area is changing after the improve-
ment of socioeconomic status and the quality of hygiene and sanitation; only 8.7% was posi-
tive for anti-HAV among children, 4 - 16 years of age, during 1998 and 1999 (Jutavijittum
and Toriyama, in preparation for publication). Fortunately these environmental factors might
control the spreading of heapatitis E in the same way of hepatitis A in Northern Thailand. In
addition to the improvement of the quality of hygiene and sanitation, HEV vaccine, which is
still under development, should be the important method to prevent and eradicate HEV in-
fection in endemic areas.
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